شیوع اختلال چربی خون و تعیین کننده های آن در شهر جهرم: یک مطالعه مقطعی-تحلیلی جمعیتی

نویسندگان
فرهنگ هوشمند 1
محمد شجاعی 2
کرامت اله رحمانیان 3
1 استادیار، بخش آسیب شناسی، دانشگاه علوم پزشکی جهرم، جهرم، ایران
2 استاد،مرکز تحقیقات بیماری های غیرواگیر، دانشگاه علوم پزشکی جهرم، جهرم، ایران
3 دانشیار،مرکز تحقیقات مولفه های اجتماعی سلامت،دانشگاه علوم پزشکی جهرم، جهرم، ایران
10.52547/jmj.18.3.49
چکیده
مقدمه: اختلال چربی خون (Dyslipidemia) یکی از عوامل شناخته شده و قابل پیشگیری بیماری کرونر قلب است. هدف این مطالعه تعیین شیوع اختلال چربی خون و برخی عوامل مرتبط با آن در بالغین شهری جهرم، ایران بود.
روش کار: این مطالعه مقطعی- تحلیلی روی 891 نفر از ساکنین 30 سال به بالای شهر جهرم در استان فارس، ایران، انجام شد. داده هایی همچون سن، جنسیت، میزان تحصیلات، وضعیت تأهل و شاخص توده بدنی جمع آوری شد. مقدار p کمتر از 0.05 به عنوان سطح
معنا داری آماری در نظر گرفته شد.
یافته ها: به طور کلی، شیوع اختلال چربی خون در افراد شرکت کننده در این مطالعه 78.1 درصد (فاصله اطمینان 95%: 80.8 - 75.4%) بود. شیوع هیپرکلسترولمی، هیپرتری گلیسیریدمی، LDL-C بالا و HDL-C پایین در افراد مورد مطالعه به ترتیب برابر 46.8 درصد، 40.0 درصد، 41.6 درصد و 42.8 درصد بود. شیوع اختلال چربی خون در زنان (83.6 درصد) به طور معناداری بیشتر از مردان (71.5 درصد) بود ( p=0.001). جنسیت (زن)، اضافه وزن و چاقی از عوامل خطر اختلال چربی خون بودند.
نتیجه گیری: اختلال چربی خون در جنوب ایران از مشکلات عمده سلامت هستند. بنابراین، برنامه غربالگری بایستی در نواحی شهری جهرم به منظور شناسایی زود هنگام اختلال چربی خون انجام شود. توجه به چاقی و اضافه وزن برای تغییر سبک زندگی افراد مبتلا به اختلال چربی خون ضروری هستند.
کلیدواژه‌ها
جنسیت
چاقی
لیپوپروتئین
عامل خطر
جهرم

عنوان مقاله English

Prevalence of Dyslipidemia and its Determinants in Jahrom: a Population-based Cross-sectional Study

نویسندگان English

Farhang Hooshmand 1
Mohammad Shojaei 2
Karamatollah Rahmanian 3
1 Assistant Professor, Pathology Ward, Jahrom University of Medical Sciences, Jahrom, Iran
2 Professor, Research Center for Non-Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran
3 Associate Professor, Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran
چکیده English

Introduction: Dyslipidemia is a well-recognized and preventable risk factor for Coronary heart disease (CHD). The aim of this population-based study was to determine the prevalence of dyslipidemia and its some related factors in urban adults in Jahrom, Iran.
Materials & Methods: This cross-sectional study was conducted among 891 adult aged 30 years or older in urban population in Jahrom, Fars province, Iran. Data such as sex, age, education level, marital situation, and body mass index (BMI) were collected. The p< 0.05 was considered as statistically significant.
Results: Overall, the prevalence of dyslipidemia was 78.1% (95% Confidence Interval: 75.4-80.8%) in the participants. The prevalence of hypercholesterolemia, hypertriglyceridemia, high low-density lipoprotein cholesterol (LDL-C), and low high-density lipoprotein cholesterol (HDL-C) was 46.8%, 40.0%, 41.6%, and 42.8%, respectively, among in study subjects. The prevalence of dyslipidemia was significantly higher in women (83.6%) in compare to men (71.5%, p= 0.001). Sex (female), overweight and obesity, were risk factors for dyslipidemia.
Conclusion: Dyslipidemia is a major health problem in south of Iran. Therefore, screening programs should be carried out in the urban area of Jahrom for early detection of dyslipidemia. Focusing on overweight and obesity are essential to changing lifestyles among subjects with dyslipidemia.

کلیدواژه‌ها English

Sex
Obesity
Lipoprotein
Risk Factor
Jahrom
1. Ahmed SM, Clasen ME, Donnelly JE. Management of dyslipidemia in adults. Am Fam Physician. 1998;57(9):2207-8. 2. Zhang F-L, Xing Y-Q, Wu Y-H, Liu H-Y, Luo Y, Sun M-S, et al. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey. Lipids in Health and Disease. 2017;16:61. 3. Pletcher MJ, Bibbins-Domingo K, Liu K, Sidney S, Lin F, Vittinghoff E, et al. Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Ann Intern Med. 2010;153(3):137-46. 4. World Health Organization. The top ten causes of death. WHO fact sheet. Available from: URL: http://www.who.int/mediacentre/fact-sheets/fs310/en/index.html (Accessed Date: July 2011). 5. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(1):442. 6. WHO: Global status report on noncommunicable diseases 2014. In. Geneva: World Health Organization. 2014 7. Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol. 2004;14(3):125-38. 8. American Dietetic Association; Dietitians of Canada. Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets. J Am Diet Assoc. 2003;103:748-65. 9. Toth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the united states: the national health and nutrition examination survey 2003-2006. Journal of clinical lipidology. 2012;6:325-30. 10. Popa S, Mota M, Popa A, Mota E, Timar R, Serafinceanu C, et al. Prevalence of dyslipidemia and its association with cardiometabolic factors and kidney function in the adult Romanian population: The PREDATORR study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(1):596-602. 11. Ramón-Arbués E, Martínez-Abadía B, Gracia-Tabuenca T, Yuste-Gran C, Pellicer-García B, Juárez-Vela R, et al. [Prevalence of overweight/obesity and its association with diabetes, hypertension, dyslipidemia and metabolic syndrome: a cross-sectional study of a sample of workers in Aragón, Spain]. utricion Hospitalaria. 2019;36(1):51-9. [Spanish] 12. Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandania VK, et al. Prevalence of dyslipidemia in urban and rural India: The ICMR-INDIAB study. PLoS One. 2014;9(5):e96808. 13. Dung PT, Hung NT, Vuong DV, Chinh PTK, Duong PH, Nhung NT. Prevalence of Dyslipidemia and Associated Factors among Adults in Rural Vietnam. Sys Rev Pharm. 2020;11(1):185-91. 14. Supiyev A, Nurgozhin T, Zhumadilov Z, Peasey A, Hubacek JA, Bobak M. Prevalence, awareness, treatment and control of dyslipidemia in older persons in urban and rural population in the Astana region, Kazakhstan. BMC Public Health. 2017;17:651. 15. TABRIZI JS, NIKNIAZ L, SADEGHI-BAZARGANI H, FARAHBAKHSH M, NIKNIAZ Z, ABBASALIZAD-FARHANGI M, et al. Prevalence of Dyslipidemia in Urban and Rural Areas of the Northwest of Iran: The Sociodemographic, Dietary and Psychological Determinants. Iran J Public Health. 2019;48(5):925-33. 16. Tabary M, Cheraghian B, Mohammadi Z, Rahimi Z, Naderian MR, Danehchin L, et al. Association of anthropometric indices with cardiovascular disease risk factors among adults: a study in Iran. European Journal of Cardiovascular Nursing. 2020;https://doi.org/10.1093/eurjcn/zvaa007. 17. Preparation of the Global Strategy for Diet, Physical Activity and Health- Report of a regional consultation. World Health Organization, Regional Office for the Eastern Mediterranean, Cairo. 2013. 18. Rahmanian K, Shojae M, Eftekhareian F. Frequency of Awareness, Treatment, and Control of Hypertension in Individuals Aged 30 years or older: A Cross-Sectional Study in Urban Population. Pars Journal of Medical Sciences. 2020;17(4):39-46. 19. Hernández-Alcaraz C, Aguilar-Salinas CA, Mendoza-Herrera K, Pedroza-Tobías A, Villalpando S, Shamah-Levy T, et al. Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012. salud pública de méxico. 2020;62(2):137-46. 20. Zarif.Yeganeh M, Shakersain B, Azizi F, Yngve A, Hedayati M. Central Obesity As A Reliable Predictor for Hypertension and Dyslipidemia: Tehran Lipid Glucose Study. Iranian Journal of Endocrinology and Metabolism. 2010;12(3):251-9. 21. Basit A, Sabir S, Riaz M, Fawwad A, Abro MUR, Ahmed KI, et al. NDSP 05: Prevalence and pattern of dyslipidemia in urban and rural areas of Pakistan; a sub analysis from second National Diabetes Survey of Pakistan (NDSP) 2016–2017. Journal of Diabetes & Metabolic Disorders. 2020. 22. Gebreyes YF, Goshu DY, Geletew TK, Argefa TG, Zemedu TG, Lemu KA, et al. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015. PLoS ONE. 2018;13(5):e0194819.